Teng J Peng, MD
Clinical Assistant Professor
On This Page
About Teng J Peng
Teng J. Peng, MD is an assistant professor in the division of vascular neurology at the University of Florida College of Medicine
Dr. Peng earned his undergraduate and medical degree at Boston University. He then completed a one-year internal medicine internship at the University of Massachusetts Medical Center, a three-year neurology residency at Yale New Haven Hospital, and a one-year vascular neurology fellowship also at Yale New Haven Hospital. Prior to UF, he worked as a clinical instructor of Neurology at Yale University while completing a one-year- StrokeNet NIH research fellowship.
He is fluent in English and Spanish, and can converse in Mandarin Chinese. In his free time he enjoys traveling, eating good food, reading, and spending time with my family. He is an advocate of medical education and his research interests include the treatment and outcomes of neurovascular diseases, such as ischemic and hemorrhagic stroke.
Accomplishments
-
StrokeNET SPIRIT Clinical Trial Award
Southern New England Partnership in Stroke Research, Innovation, and Treatment (SPIRIT)
-
UMass Intern of the Year Award
University of Massachusetts
-
AAN Medical Student Prize for Excellence
American Academy of Neurology
-
APS-SPR Research Award
American Pediatric Society – Society of Pediatric Research
Teaching Profile
Courses Taught
-
PAS5020 – Intro to Medicine 2
College of Medicine
-
MDC7800 – Neurology Clerkship
College of Medicine
Clinical Profile
Specialties
- Neurology
- Vascular Neurology
Areas of Interest
- Acute Ischemic Stroke
- Recovering After Stroke
- Stroke
Publications
Academic Articles
Grants
-
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Intrathecally Administered ALN-APP in Patients with Cerebral Amyloid Angiopathy (CAA), with Protocol number ALN-APP-002 (collectively, “Study Drug”)
Active
- Role:
- Principal Investigator
- Funding:
- IQVIA RDS via ALNYLAM PHARMACEUTICALS
-
Brain and Spinal Cord Injury Research
Active
- Role:
- Project Manager
- Funding:
- FL DEPT OF HLTH
-
A multicenter, international, randomized, placebo controlled, double-blind, parallel group and event driven Phase 3 study of the oral FXIa inhibitor asundexian (BAY 2433334) for the prevention of ischemic stroke in male and female participants aged 18 years and older after an acute non-cardioembolic ischemic stroke or high-risk TIA
Active
- Role:
- Principal Investigator
- Funding:
- BAYER HEALTHCARE PHARMACEUTICALS
-
Perioperative Cognitive Anesthesia Network Extension for Socially Vulnerable Older Adults
Active
- Role:
- Project Manager
- Funding:
- NATL INST OF HLTH NIA
-
BRAIN AND SPINAL CORD INJURY RESEARCH
- Role:
- Project Manager
- Funding:
- FL DEPT OF HLTH
Education
-
StrokeNET Research Fellow
Yale University School of Medicine
-
Neurovascular Fellow
Yale University School of Medicine
-
Chief Neurology Resident
Yale University School of Medicine
-
Neurology Resident
Yale University School of Medicine
-
Internal Medicine Intern
University of Massachusetts Medical Center
-
MD
Boston University School of Medicine
-
BA, Psychology
Boston University
-
BS, Human Psychology
Boston University
Contact Details
- Business:
- (352) 294-5400
- Business:
- tpengzhao@ufl.edu
- Business Street:
-
1329 SW 16TH ST RM 1160
GAINESVILLE FL 32608